Financhill
Sell
34

KALV Quote, Financials, Valuation and Earnings

Last price:
$8.68
Seasonality move :
-3.06%
Day range:
$8.90 - $9.15
52-week range:
$7.97 - $16.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
30.44x
P/B ratio:
3.33x
Volume:
152.4K
Avg. volume:
384.8K
1-year change:
-25.56%
Market cap:
$446.2M
Revenue:
--
EPS (TTM):
-$3.69

Earnings Data

Next earnings date for KALV
Mar 11
2025
Most recent earnings per share
-$0.91
Missed by $0.00
(Dec 5/2024)
Consensus Estimate
-$0.91
(Dec 5/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

KALV Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/11/2025 Q1 -- -- -- -$0.88 --
12/05/2024 Q4 -- -- -$0.91 -$0.91 -$0.00
09/05/2024 Q3 -- -- -$0.87 -$0.95 $0.08
07/11/2024 Q2 -- -- -$1.07 -$0.72 -$0.35
03/11/2024 Q1 -- -- -$0.84 -$0.80 -$0.04
12/07/2023 Q4 -- -- -$0.80 -$0.78 -$0.02
09/07/2023 Q3 -- -- -$0.74 -$0.84 $0.10
04/30/2023 Q2 -- -- -$0.77 -$0.83 $0.06
03/09/2023 Q1 -- -- -$0.75 -$1.00 $0.25
12/08/2022 Q4 -- -- -$0.90 -$1.05 $0.15
09/08/2022 Q3 -- -- -$0.94 -$0.97 $0.03
04/30/2022 Q2 -- -- -$0.98 -$1.09 $0.11
03/10/2022 Q1 -- -- -$0.92 -$0.90 -$0.02
12/09/2021 Q4 -- -- -$0.80 -$0.75 -$0.05
09/09/2021 Q3 -- -- -$0.66 -$0.72 $0.06
07/13/2021 Q2 -- -- -$0.65 -$0.54 -$0.11
03/11/2021 Q1 -- -- -$0.56 -$0.59 $0.03
12/10/2020 Q4 -- -- -$0.58 -$0.66 $0.08
09/14/2020 Q3 -- -- -$0.61 -$0.55 -$0.07
07/01/2020 Q2 -- -- -$0.37 -$0.61 $0.24
03/10/2020 Q1 -- -- -$0.52 -$0.52 --
12/03/2019 Q4 -- -- -$0.33 -$0.54 $0.21
09/09/2019 Q3 -- -- -$0.42 -$0.59 $0.17
07/15/2019 Q2 -- -- -$0.49 -$0.35 -$0.14
03/15/2019 Q1 -- -- -$0.23 -$0.46 $0.23
12/14/2018 Q4 -- -- -$0.22 -$0.42 $0.20
07/31/2018 Q3 -- -- -$0.47 -$0.33 -$0.14
04/30/2018 Q2 -- -- -$0.04 -$0.35 $0.31
03/16/2018 Q1 -- -- -$0.49 -$0.13 -$0.36
12/14/2017 Q4 -- -- -$0.50 -$0.45 -$0.05
10/10/2017 Q3 -- -- -$0.51 -$0.59 $0.08

KalVista Pharmaceuticals Earnings Questions

  • How Much did KalVista Pharmaceuticals Generate in Revenue Last Quarter?

    KalVista Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did KalVista Pharmaceuticals Beat Earnings Last Quarter?

    KalVista Pharmaceuticals announced earnings per share of -$0.91 which represents a miss of analyst forecast a -$0.91 per share.

  • Is KalVista Pharmaceuticals Profitable?

    KalVista Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for KalVista Pharmaceuticals EPS Next Year?

    KalVista Pharmaceuticals's earnings are forecast to decrease from -$3.44 per share to -$3.04 per share next year representing a decrease of -6.01%.

  • When is KalVista Pharmaceuticals's Earnings Date?

    KalVista Pharmaceuticals's next earnings date is March 11, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will American Tower Stock Recover?
Will American Tower Stock Recover?

The performance of the real estate investment trust, or REIT,…

Will Booking Holdings Stock Split?
Will Booking Holdings Stock Split?

Booking Holdings, the travel and technology company that owns brands…

Why Buy Domino’s Pizza Stock?
Why Buy Domino’s Pizza Stock?

When you think of growth stocks, you probably imagine technology…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 121x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
70
OKLO alert for Jan 6

Oklo [OKLO] is up 10.09% over the past day.

Sell
39
DOGZ alert for Jan 6

Dogness (International) [DOGZ] is up 3.39% over the past day.

Buy
66
DMRC alert for Jan 6

Digimarc [DMRC] is up 1.05% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock